Arvee Laboratories (India) Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: ARVEE | Chemicals | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Arvee Laboratories

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Undervalued

3. Price Trend

Semi Strong

Arvee Laboratories (India) stock performance -

P/E Ratio (SA):
72.83
Market Cap:
159.8 Cr.
52-wk low:
0
52-wk high:
0

Is Arvee Laboratories (India) Ltd an attractive stock to invest in?

1. Is Arvee Laboratories (India) Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Arvee Laboratories (India) Ltd is a good quality company.

2. Is Arvee Laboratories (India) Ltd undervalued or overvalued?

The key valuation ratios of Arvee Laboratories (India) Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Arvee Laboratories (India) Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Arvee Laboratories (India) Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Arvee Laboratories:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Arvee Laboratories (India) Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 7.5%14.4%15.2%17.7%14.1%15.8%16%13.3%23.4%7%-
Value Creation
Index
-0.50.00.10.30.00.10.1-0.10.7-0.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 1326.834.447.854.945.447.440.361.430.438
Sales YoY Gr.-106.8%28.3%38.8%14.9%-17.3%4.3%-14.9%52.1%-50.5%-
Adj EPS -2.80.21.912.122.52.330.92
YoY Gr.-NA734.8%-48.4%107.1%-4.4%25%-6.5%31.9%-71.5%-
BVPS (₹) 2.43.35.212.714.816.919.421.725.526.428.3
Adj Net
Profit
-1.70.21.61.12.32.22.72.53.312
Cash Flow from Ops. 8.66.2469.510.31.742.93.7-
Debt/CF from Ops. 2.44.16.22.71.40.45.20.80.30.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 9.9%-11.2%-13.8%-50.5%
Adj EPS NA-16%-29.5%-71.5%
BVPS30.8%12.3%10.9%3.8%
Share Price - 25.3% 7.7% -17.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
-73.69.245.411.814.812.213.411.112.83.37.3
Op. Profit
Mgn %
16.117.516.31511.313.312.81411.99.711
Net Profit
Mgn %
-12.70.74.52.34.14.75.76.35.43.15.7
Debt to
Equity
14.79.661.20.80.20.40.100-
Working Cap
Days
266187182167140124123167127271126
Cash Conv.
Cycle
13270836453332553438587

Recent Performance Summary

Sales growth is good in last 4 quarters at 11.18%

Return on Equity has declined versus last 3 years average to 7.30%

Sales growth has been subdued in last 3 years -13.80%

Net Profit has been subdued in last 3 years -29.46%

Latest Financials - Arvee Laboratories (India) Ltd.

Standalone Consolidated
TTM EPS (₹) 2 -
TTM Sales (₹ Cr.) 38.2 -
BVPS (₹.) 28.3 -
Reserves (₹ Cr.) 20 -
P/BV 5.12 -
PE 72.83 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 160
Equity (₹ Cr.) 11
Face Value (₹) 10
Industry PE 51.6

Quarterly Results

 Mar'24 YoY Gr. Rt. %Jun'24 YoY Gr. Rt. %Sep'24 YoY Gr. Rt. %Dec'24 YoY Gr. Rt. %
Sales (₹ Cr.) 6.1 -51.110.6 39.512.5 40.68.9 15.7
Adj EPS (₹) 0.1 10000.9 93.20.9 368.40.1 -36.4
Op. Profit Mgn % 12.97 375 bps14.50 156 bps11.99 422 bps3.91 -290 bps
Net Profit Mgn % 1.89 181 bps8.89 248 bps7.83 547 bps1.74 -135 bps

Management X-Ray of Arvee Laboratories:

Shareholding Pattern

JavaScript chart by amCharts 3.21.5
JavaScript chart by amCharts 3.21.5Promoters:73.5%Institutions:0%Non-Institutions:26.5%

Promoter's Holding & Share Pledging

JavaScript chart by amCharts 3.21.5Sep22Dec22Mar23Jun23Sep23Dec23Mar24Jun24Sep24Dec240%20%40%60%80%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Arvee Laboratories

MRP
spaceLock icon
MOS
spaceLock icon%
DP
spaceLock icon
Base EPS
spaceLock icon
DPS
spaceLock icon
MRP: ₹ 0
DP: ₹0
Base EPS ₹:
DPS ₹:
MOS (%):
Expected EPS Growth Rate:
0%
Base 0%
50%
Expected Rate of Return:
0%
Base 0%
50%
Future PE:
0
Base 0
200
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max

Event Update

Login/Register to view analysis.

Analyst's Notes

No data found!

Key Ratios of Arvee Laboratories

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Company Name CMP(₹)
Change ₹(%)
Market Cap
Net Sales (₹ Cr.)
Latest EPS (₹)
Net Profit Margin %
Latest P/E
Latest P/BV
Tata Chemicals 849.3 -2.7 (-0.3%) Small Cap 15,421 -21.9 6.9 - 1
GNFC 504.5 3.3 (0.7%) Small Cap 7,930 34.2 6.2 14.8 0.9
Aarti Inds 398.2 -2.7 (-0.7%) Small Cap 6,372 10.1 6.6 39.3 2.6
Atul 5,625.4 -207.2 (-3.6%) Small Cap 4,358 137.7 8.5 40.8 2.9
Himadri Speciality 456.6 1.8 (0.4%) Small Cap 4,185 10.4 9.6 43.8 6.5
Jubilant Ingrevia 670.1 18.1 (2.8%) Small Cap 3,987 12.8 4.2 52.4 4.5
Chemplast Sanmar 434.1 0.5 (0.1%) Small Cap 3,923 -5.5 -3.8 - 38.5
Guj. Alkalies & Chem 660.1 11 (1.7%) Small Cap 3,807 -3.7 -3.5 - 0.7
GHCL 621.8 -17.3 (-2.7%) Small Cap 3,447 62.5 18 9.9 1.8
India Glycols 1,257 76.4 (6.5%) Small Cap 3,291 54.2 4.9 23.2 2.1
Shows rows:

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales13273448554547406130
Operating Expenses 11222941493941355427
Manufacturing Costs1235433354
Material Costs7172230392929223915
Employee Cost 2233336666
Other Costs 1113343343
Operating Profit 2567666673
Operating Profit Margin (%) 16.1%17.5%16.3%15.0%11.2%13.3%12.7%13.9%11.9%9.7%
Other Income 0010001111
Interest 2333211000
Depreciation 1122222221
Exceptional Items 0000000000
Profit Before Tax -1112334362
Tax 10-11011121
Profit After Tax -2021223341
PAT Margin (%) -12.7%0.7%4.5%2.3%4.1%5.1%5.7%6.4%6.7%3.5%
Adjusted EPS (₹)-2.80.21.91.02.12.12.42.33.71.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 13414161921242829
Share Capital 34466611111111
Reserves -2-109111310131718
Minority Interest0000000000
Debt212424151149311
Long Term Debt1517178321111
Short Term Debt6677828200
Trade Payables36612610101087
Others Liabilities 1323311222
Total Liabilities 26353644373441393939

Fixed Assets

Gross Block10162122222427303132
Accumulated Depreciation124791114161820
Net Fixed Assets9131715131314141313
CWIP 5401221123
Investments 0000232000
Inventories6768567656
Trade Receivables2681587812126
Cash Equivalents 1112417512
Others Assets3332422179
Total Assets 26353644373441393939

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 96469102434
PBT -1112334362
Adjustment 3455332221
Changes in Working Capital 61-3-145-3-1-41
Tax Paid 001-10-1-1-1-20
Cash Flow From Investing Activity -6-5-1-1-3-3-10-1-2
Capex -6-5-1-1-2-2-2-2-1-3
Net Investments 0000-2-11200
Others 0000101000
Cash Flow From Financing Activity -2-1-3-4-5-105-6-20
Net Proceeds from Shares 0109000000
Net Proceeds from Borrowing 003-9-40-1-6-20
Interest Paid -2-3-3-3-1-10000
Dividend Paid 0000000000
Others 01-3-11-96000
Net Cash Flow 10012-36-2-11
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)-73.589.2445.4112.0114.9713.1713.3811.3615.843.68
ROCE (%)7.5114.3915.1917.6914.115.7915.9913.3323.357.03
Asset Turnover Ratio0.60.880.971.21.351.281.271.011.590.79
PAT to CFO Conversion(x)N/AN/A264.550.671.330.754
Working Capital Days
Receivable Days645276917858559173111
Inventory Days131917055424554603166
Payable Days9297991118510012115882181

Arvee Laboratories (India) Ltd Stock News

Arvee Laboratories (India) Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Arvee Laboratories on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Arvee Laboratories stood at ₹159.8.
The latest P/E ratio of Arvee Laboratories as of 01-Jan-1970 05:30 is 72.83.
The latest P/B ratio of Arvee Laboratories as of 01-Jan-1970 05:30 is 5.12.
The 52-week high of Arvee Laboratories is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Arvee Laboratories is ₹38.18 ( Cr.) .

About Arvee Laboratories (India) Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...